Pricing Log in Create free account

Arcturus Therapeutics Holdings Inc. (ARCT) vs Enanta Pharmaceuticals, Inc. (ENTA)

Arcturus Therapeutics Holdings Inc. and Enanta Pharmaceuticals, Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and Enanta Pharmaceuticals, Inc. are of similar size ($334.1M and $320.3M). Enanta Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 0.70% against −76.0%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −317.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Enanta Pharmaceuticals, Inc. leads on 11 and Arcturus Therapeutics Holdings Inc. on 4.

Valuation

Metric ARCT ENTA Biotechnology median
P/E n/m n/m 8.50
P/S 10.01 4.95 9.71
P/B 1.71 3.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.06 2.04 9.21
Earnings yield (32.01%) (21.71%) (33.15%)
Free cash flow yield (24.76%) (11.44%) (25.50%)

Profitability

Metric ARCT ENTA Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (348.32%) (89.99%) 0.00%
Net margin (317.61%) (96.89%) 0.00%
Free cash flow margin (247.79%) (56.60%) 0.00%
Return on equity (46.31%) (70.12%) (56.36%)
Return on assets (34.96%) (21.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARCT ENTA Biotechnology median
Revenue growth (TTM) (75.95%) 0.70% 6.02%
EPS growth (last fiscal year) 20.00% 29.93% 30.26%
Revenue growth, 5-year CAGR 53.78% (11.81%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARCT ENTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.88 3.76 4.72
Net debt to EBITDA 3.15 2.35 0.96

Dividend

Metric ARCT ENTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARCT ENTA Biotechnology median
Market cap 320.32m 334.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack